Brief: GenScript Partners With Allozymes To Accelerate Protein Discovery, Target Identification
07/12/2022 11:12
Dec 7 (Reuters) - GenScript Biotech Corp 1548.HK :
* GENSCRIPT PARTNERS WITH ALLOZYMES TO ACCELERATE PROTEIN
DISCOVERY AND TARGET IDENTIFICATION
Source text for Eikon: ID:nPn94n4nra
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale